Early-warning fungal detection and mycotoxin screening system
Centaur Science offers a TRL-9 validated lateral flow assay platform for early detection of fungal contamination in grain, enabling pre-symptomatic intervention to prevent mycotoxin synthesis. The system integrates an electronic reader for real-time data reporting, enhancing supply chain oversight.
Overview
Centaur Science introduces an advanced solution for early detection of fungal contamination in grain supplies with its client's TRL-9 validated lateral flow assay (LFA) platform. This technology enables proactive intervention by identifying high fungal loads before mycotoxins are synthesized, thus preventing costly contamination. The system is designed to provide rapid, reliable, and quantitative assessments of fungal biomass across more than 23 fungal genera, offering a substantial advantage over traditional, slower lab-based methods.
Technical specifications
The core of this detection system is a broad-spectrum LFA platform that integrates with an electronic reader. The reader transmits quantitative data via app-generated reports, allowing for real-time monitoring and decision-making in supply chains. The platform is currently optimized for agricultural matrices and is capable of keeping up with industrial-scale throughput demands. The next-generation development aims to integrate specific mycotoxin assays into a multiplexed format, featuring a modular architecture for expanded testing capabilities.
Key features include:
- Broad-spectrum detection of 23+ fungal genera
- TRL-9 validation, ensuring commercial readiness and reliability
- Compatibility with high-throughput industrial environments
- Electronic reader system for immediate, actionable insights
Technology readiness level
This innovative detection system is at Technology Readiness Level 9, indicating that it has been proven in operational environments and is ready for full-scale deployment. Future validation plans involve further integration of mycotoxin-specific assays and modular enhancements to expand its capabilities.
About Centaur Science Incorporated
Centaur Science Incorporated (CSI) is a contract research and consulting firm specializing in microbiology, cell biology, biochemistry, and molecular biology. The company functions as an outsourced R&D department, offering services ranging from laboratory testing and characterization to product development support and grant writing. Their team utilizes scientific expertise to assist innovators, manufacturers, and researchers in overcoming technical challenges, bridging the gap between academic research and standardized industry product development.
CSI serves clients including startups, established biotech companies, and government agencies, particularly those working on new antimicrobials, diagnostics, and therapies, as well as food and veterinary sectors. By providing bespoke laboratory programs rather than generic solutions, the company focuses on rigorous, reliable support to help partners characterize microorganisms, validate new products, and navigate complex scientific research requirements. Their approach emphasizes competence and innovation, tailored to meet the specific R&D needs of each unique project.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.